Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository.
Saved in:
| Title: | Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository. |
|---|---|
| Authors: | Pasternak AL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA., Seda R; University of Michigan Data Office for Clinical and Translational Research, University of Michigan Medical School, Ann Arbor, Michigan, USA., Lipa J; Health Information Technology & Services (HITS) at Michigan Medicine, Ann Arbor, Michigan, USA., McDevitt RL; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Crysler OV; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Swiecicki PL; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Schneider BJ; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Vanderwerff B; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA., Henry NL; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Krauss JC; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Sahai V; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Aug; Vol. 114 (2), pp. 356-361. Date of Electronic Publication: 2023 May 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-6535 |
|---|---|
| DOI: | 10.1002/cpt.2936 |
